Large proteomic studies identified angiopoietin-like protein 4 (Angptl4) and angiostatin as useful urinary biomarkers for tracking renal disease activity and kidney pathology in patients with SLE [11,12,80]. This evidence concerns the gene ANGPTL4 and systemic lupus erythematosus.